M&A Deal Summary

Abbott Laboratories Acquires Knoll Pharmaceutical

On December 15, 2000, Abbott Laboratories acquired life science company Knoll Pharmaceutical from BASF for 6.9B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 1st transaction in the Life Science sector.
  • This is Abbott Laboratories’ 2nd largest (disclosed) transaction.
  • This is Abbott Laboratories’ 4th transaction in the United States.
  • This is Abbott Laboratories’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2000-12-15
Target Knoll Pharmaceutical
Sector Life Science
Buyer(s) Abbott Laboratories
Sellers(s) BASF
Deal Type Add-on Acquisition
Deal Value 6.9B USD

Target

Knoll Pharmaceutical

Mount Olive, New Jersey, United States
Knoll is a US-based drug discovery company with experimental drugs for advanced pain, psychosis, heart disease, asthma, lupus and a range of other so-called autoimmune illnesses.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 4 of 35
Sector (Life Science) 1 of 11
Type (Add-on Acquisition) 4 of 35
State (New Jersey) 1 of 3
Country (United States) 4 of 27
Year (2000) 1 of 1
Size (of disclosed) 2 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-07-09 Perclose

Redwood City, California, United States

Perclose is a provider of suturing systems that rapidly close wounds after doctors perform coronary-artery angioplasty procedures.

Buy $680M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-10-24 Vysis

Downers Grove, Illinois, United States

Vysis produces diagnostic tests which detect genetic changes in cells.

Buy $355M

Seller(S) 1

SELLER

BASF

Ludwigshafen, Germany
Category Company
Founded 1865
Sector Chemicals
Employees111,855
Revenue 68.9B EUR (2023)
DESCRIPTION
Entrance to BASF's office in Florham Park, New Jersey.
Entrance to BASF's office in Florham Park, New Jersey.

BASF is a global producer of chemicals. BASF looks to combine economic success with environmental protection and social responsibility. BASF was founded in 1865 and is based in Ludwigshafen, Germany.

DEAL STATS #
Overall 1 of 26
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 2
State (New Jersey) 1 of 1
Country (United States) 1 of 7
Year (2000) 1 of 1
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-01-01 Chemdal International

Arlington Heights, Illinois, United States

Chemdal International Corp. manufactures and markets chemical and synthetic rubber products including superabsorbers.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-05-08 DyStar

Frankfurt, Germany

DyStar is a global provider of dyes and services to the fashion and textile industries. With operations in countries in Europe, Asia, Africa, and the Americas, DyStar manufactures, sells and distributes a wide range of dyestuffs and pigment preparations. DyStar has a solid market position, long-term relationships with key customers, and is well-known globally for its innovative products.

Sell -
Mergr

Product

Company

Legal